1st Quarter 2026
Key topics in this quarter’s edition include:
- Icotrokinra for the treatment of plaque psoriasis
- Orforglipron to reduce body weight in patients with obesity or with overweight
- Ensitrelvir for post-exposure prophylaxis for COVID-19 infection